Publisher: John Wiley & Sons Inc
E-ISSN: 1532-6535|97|4|372-379
ISSN: 0009-9236
Source: CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.4, 2015-04, pp. : 372-379
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Disrupted vasculature and blood–brain barrier in Huntington disease
ANNALS OF NEUROLOGY, Vol. 78, Iss. 2, 2015-08 ,pp. :
Innate Immunity in Viral Infections
Journal of Innate Immunity, Vol. 1, Iss. 5, 2009-06 ,pp. :
Blood–brain barrier: An impediment to neuropharmaceuticals
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. :
Brain targeting PBCA nanoparticles and the blood––brain barrier
By Wilson B
Nanomedicine, Vol. 4, Iss. 5, 2009-07 ,pp. :